TY - JOUR T1 - Minimal Anticipated Biological Effect Level of Anti-CD28 Receptor Antagonist JF - Journal of Pharmacology and Experimental Therapeutics JO - J Pharmacol Exp Ther SP - 351 LP - 351 DO - 10.1124/jpet.115.1215HIc VL - 355 IS - 3 A2 - , Y1 - 2015/12/01 UR - http://jpet.aspetjournals.org/content/355/3/351.4.abstract N2 - ER -